Sfoglia per AUTORE
LADETTO M
Collezione AO Alessandria

  

Items : 71

Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression). in Leukemia / Leukemia. 2023 Sep;37(9):1887-1894. doi: 10.1038/s41375-023-01977-y. Epub 2023 Jul 26.

2023
AO Alessandria
AOU Città della Salute di Torino

Ladetto M; Evangelista A; Klapper W; Unterhalt M; Rosenwald A; Schmidt C; Kluin-Nelemans HC; Jiang L; Hermine O; Scheubeck G; Jerkeman M; Ferrero S; Dreyling M; Hoster E;

The black swan: a case of central nervous system graft-versus-host disease. in Journal of basic and clinical physiology and pharmacology / J Basic Clin Physiol Pharmacol. 2023 Oct 17. doi: 10.1515/jbcpp-2023-0194.

2023
AO Alessandria

Butera S; Tavarozzi R; Brunello L; Rivela P; Sofia A; Viero L; Salvio M; Ladetto M; Zallio F;

Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2023 Nov 3:S0923-7534(23)04240-0. doi: 10.1016/j.annonc.2023.10.095.

2023
AO Alessandria
AOU Novara

Luminari S; Pennese E; Re F; Benedetti F; Patti C; Ferreri AJM; Latte G; Pastore D; Pinto A; Ghiggi C; Milone G; Cavallo F; Tani M; Corradini P; Pavone V; Gaidano G; Puccini B; Arcari A; Zilioli VR; Bolis S; Volpetti S; Botto B; Tucci A; Ferrero S; Evangelista A; Zanni M; Tavarozzi R; Ladetto M; Bossi E; et alii...

The role of Bruton's kinase inhibitors (BTKi) in accelerated Chronic Lymphocytic Leukemia (a-CLL): a case of successful response to acalabrutinib. in Journal of basic and clinical physiology and pharmacology / J Basic Clin Physiol Pharmacol. 2023 Apr 12;34(3):401-404. doi: 10.1515/jbcpp-2023-0051. eCollection

2023
AO Alessandria

Catania G; Tavarozzi R; Pini GM; Borra T; Gandolfo C; Zacchi G; Pietrasanta D; Monaco F; Zanni M; Lettieri M; Rivela P; Zallio F; Ladetto M;

Corrigendum to "Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 31 (2020) 17-29]. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2023 Mar;34(3):325. doi: 10.1016/j.annonc.2022.11.009. Epub 2022 Dec 16.

2023
AO Alessandria

Ladetto M; Wotherspoon A; Salar A; Stamatopoulos K; Thieblemont C; Ricardi U; Raderer M; Buske C; Johnson PW; Ponzoni M; Zucca E; Arcaini L;

OVERALL SURVIVAL ADVANTAGE OF MONOCLONAL ANTIBODIES BASED-TREATMENTS IN MULTIPLE MYELOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION in HemaSphere

2023
AOU Città della Salute di Torino
AO Alessandria

Nozzoli C; Pucillo M; Martino M; Giaccone L; Rambaldi A; Benedetti E; Russo D; Mordini N; Bernasconi P; Mangiacavalli S; Pioltelli P; Carluccio P; Galieni P; Ladetto M; Sica S; Isola M; De Martino M; Oldani E; Degrandi E; Biasco A; Fanin R; Saccardi R; Ciceri F; Patriarca F;

Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma. in Blood / Blood. 2022 Sep 22;140(12):1378-1389. doi: 10.1182/blood.2021014270.

2022
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
AO Alessandria

Ladetto M; Cortelazzo S; Cascavilla N; Ghiggi C; Liberati AM; Musuraca G; Hohaus S; Petrini M; Re F; Pavone V; Casaroli I; Zanni M; Castellino C; Mantoan B; De Luca G; Stefani PM; Benedetti F; Evangelista A; Alessandria B; Ghislieri M; Ferrante M; Genuardi E; Drandi D; Zaccaria GM; Grimaldi D; Ferrero S;

Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 Mar 1;40(7):729-739. doi: 10.1200/JCO.21.01234. Epub 2021 Oct 28.

2022
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AO Alessandria
AOU Novara

Federico M; Mannina D; Anastasia A; Dondi A; Margiotta Casaluci G; Zilioli VR; Merli A; Ladetto M; Bolis S; Pavone V; Chiarenza A; Arcari A; Skrypets T; Del Giudice I; Chauvie S; Kovalchuk S; Pinto A; Ricci F; Patti C; Stelitano C; Arcaini L; Cavallo F; Ferrero S; Marcheselli L; Guerra L; Boccomini C; Olivieri J; Farina L; Tucci A; et alii...

Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial. in British journal of haematology / Br J Haematol. 2022 Mar;196(5):1184-1193. doi: 10.1111/bjh.17971. Epub 2021 Dec 23.

2022
AO Alessandria
ASL Cuneo 1
AOU Città della Salute di Torino
AO Cuneo
AOU Novara

Vitolo U; Gaidano G; Balzarotti M; Santambrogio E; Tucci A; Pileri SA; Ladetto M; Righi S; Motta G; Moia R; Martelli M; Melle F; Di Rocco A; Ciccone G; Evangelista A; Novo M; Agostinelli C; Nassi L; Chiappella A; Diop F;

Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol. in Cancers / Cancers (Basel). 2022 Jun 18;14(12):3012. doi: 10.3390/cancers14123012.

2022
AO Alessandria

Todisco E; Roti G; Sciumè M; Pastore D; Sargentini V; Arena V; Mancini V; Massimo B; Fazi P; Martinelli G; Voso MT; Vignetti M; Amadori S; Carella AM; Albano F; Martelli MP; Venditti A; Mengarelli A; Candoni A; Fracchiolla NS; Forghieri F; Lessi F; Papayannidis C; Paolini S; Ottone T; Piciocchi A; Messina M; Marconi G; Cerchione C; et alii...

Safety and Efficacy of Subcutaneous Rituximab in Previously Untreated Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Results from an Italian Phase IIIb Study. in Advances in hematology / Adv Hematol. 2022 Jan 27;2022:5581772. doi: 10.1155/2022/5581772. eCollection 2022.

2022
AO Alessandria
AOU Novara

Petrini M; Gaidano G; Gaglione G; Massimi S; Ronci B; La Nasa G; Cardinale G; Inzoli A; Cantore N; Ferreri AJM; Cerqueti M; Santini S; Battistini R; Turrini M; Arcaini L; Caparrotti G; Murineddu M; Camera A; Marino D; Corradini P; Musto P; Stelitano C; Guarini A; Mannina D; Ferrando P; Fraticelli V; Liberati AM; Ladetto M; Consoli U; et alii...

The role of autologous haematopoietic stem-cell transplantation in mantle cell lymphoma. in The Lancet. Haematology / Lancet Haematol. 2021 Sep;8(9):e617-e619. doi: 10.1016/S2352-3026(21)00237-4.

2021
AO Alessandria

Chiappella A; Ladetto M;

Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term. in Bone marrow transplantation / Bone Marrow Transplant. 2021 Oct;56(10):2606-2609. doi: 10.1038/s41409-021-01391-x. Epub 2021 Jul 7.

2021
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria

Tarella C; Rambaldi A; Castellino C; Gianni AM; Rigacci L; Ferreri AJM; Nicoli P; Benedetti F; Vitolo U; Chiappella A; Costa A; Patti C; Barbui AM; Ferrero S; Rossi A; Magni M; Ladetto M; Corradini P; Mian M; Evangelista A; Devizzi L; Cortelazzo S;

COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. in British journal of haematology / Br J Haematol. 2021 Nov;195(3):371-377. doi: 10.1111/bjh.17704. Epub 2021 Jul 16.

2021
ASL Torino 5
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Pagano L; Corradini P; Bertù L; Petrucci L; Zaja F; Grossi PA; Musto P; Visani G; Lanza F; Cattaneo C; La Barbera EO; Mina R; Cardinali V; Galimberti S; Luppi M; Krampera M; Fracchiolla N; Bocchia M; Candoni A; Armiento D; Arcaini L; Tafuri A; Busca A; Marchesi F; Pinto A; Massaia M; Ladetto M; Venditti A; Cairoli R; et alii...

Spontaneous splenic rupture during induction therapy in acute myeloid leukemia: An unusual case. in Radiology case reports / Radiol Case Rep. 2021 Sep 1;16(11):3406-3409. doi: 10.1016/j.radcr.2021.07.087. eCollection 2021 Nov

2021
AO Alessandria

Tavarozzi R; Borra T; Catania G; Depaoli L; Corsetti MT; Gaidano V; Limberti G; Ravazzoni F; Mariani N; Zallio F; Nozza P; Ladetto M;

EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma. in HemaSphere / Hemasphere. 2021 Apr 21;5(5):e559. doi: 10.1097/HS9.0000000000000559. eCollection 2021 May.

2021
AO Alessandria

Ladetto M; Dreyling M;

Application of the Euro Clonality next-generation sequencing-based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial. in British journal of haematology / Br J Haematol. 2021 Jul;194(2):378-381. doi: 10.1111/bjh.17519. Epub 2021 May 18.

2021
AO Alessandria
AOU Città della Salute di Torino

Cordero F; Rota Scalabrini D; Ferrero S; Calogero RA; Cortelazzo S; Ladetto M; Califano C; Mannina D; Beccuti M; Alessandria B; Genuardi E; Romano G;

Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Jan;8(1):e34-e44. doi: 10.1016/S2352-3026(20)30358-6. Epub 2020 Dec 22.

2021
AO Alessandria
AOU Città della Salute di Torino

Martelli M; Vitolo U; Stelitano C; Ciccone G; Narni F; Casaroli I; Benedetti F; Stefani PM; Puccini B; Balzarotti M; Ballerini F; Ferreri AJM; Molinari AL; Arcaini L; Gomes da Silva M; Zilioli VR; Chiappella A; Re A; Pagani C; Di Rocco A; Stefoni V; Cavallo F; Zanni M; Tavarozzi R; Mian M; Ferrero S; Evangelista A; Ladetto M; Cortelazzo S; et alii...

A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma. in Future oncology (London, England) / Future Oncol. 2021 Jan;17(3):255-262. doi: 10.2217/fon-2020-0794. Epub 2020 Sep 28.

2021
AO Alessandria

Dreyling M; Tam CS; Wang M; Smith SD; Ladetto M; Huang H; Novotny W; Co M; Romano A; Holmgren E; Huang J; Gouill SL;

A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):188. doi: 10.3390/cancers14010188.

2021
AO Alessandria
AOU Città della Salute di Torino
AOU Novara

Ladetto M; Cortelazzo S; Dreyling M; Kluin-Nelemans HC; Hermine O; Vitolo U; Fabbri A; Latte G; Guarini A; Patti C; Pascarella A; Vallisa D; Spina M; Merli F; Di Renzo N; Cabras MG; Volpetti S; Tani M; Moia R; Del Giudice I; Barbero D; Genuardi E; Ghislieri M; Drandi D; Evangelista A; Passera R; Hoster E; Ferrero S; Zaccaria GM; et alii...

Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma. in Hematological oncology / Hematol Oncol. 2021 Aug;39(3):293-303. doi: 10.1002/hon.2864. Epub 2021 Mar 31.

2021
AO Alessandria
AOU Città della Salute di Torino

Ferrero S; Ladetto M; Splinter E; van Min M; Federico M; Boccadoro M; Luminari S; Vitolo U; Cortelazzo S; Zaccaria GM; Yilmaz M; Saraci E; Lo Schirico M; Clerico M; Ragaini S; Grimaldi D; Dogliotti I; Alessandria B; Cavallo F; Ferrante M; Drandi D; Genuardi E; Klous P; Mantoan B;

A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL). in British journal of haematology / Br J Haematol. 2021 Apr;193(2):280-289. doi: 10.1111/bjh.17283. Epub 2021 Jan 21.

2021
ASL Torino 4
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Vitolo U; Ciccone G; Evangelista A; Baldini L; Balzarotti M; Tucci A; Marina Liberati A; Bolis S; Stelitano C; Rusconi C; Nassi L; Corradini P; Ferrero S; Chiarenza A; Novo M; Freilone R; Volpetti S; Rattotti S; Puccini B; Rigacci L; Ladetto M; Boccomini C;

Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials in Blood Advances

2021
AO Alessandria
AOU Città della Salute di Torino

Zucca E; Sargent DJ; Morschhauser F; Kimby E; Zawettoq M; Marcus R; Hiddemann W; Hagenbeek A; Nielsen T; Morschhauser F; Rummel M; Hagenbeek A; Vitolo U; Salles GA; Shi Q; Flowers CR; Flowers CR; Dixon JG; Casulo C; Herold M; Fowler NH; Herold M; Ou F-S; Hoster E; Peterson BA; Hochster HS; Brice P; Ladetto M; Hiddemann W; et alii...

Minimal residual disease (mrd) in indolent lymphomas in Hematologic Malignancies

2021
AO Alessandria

Christiane P; Grimaldi D; Ferrante M; Coll C; Ladetto M;

Nonconventional Management of a Hyperviscosity Syndrome Failing Plasma Exchange in Plasmatology

2021
AO Alessandria

Tavarozzi R; Pollis F; Inverardi D; Depaoli L; Massaia M; Monaco F; Sacchi MV; Guaschino R; Ladetto M;

Organizational determinants of hospital stay: establishing the basis of a widespread action on more efficient pathways in medical units. in Internal and emergency medicine / Intern Emerg Med. 2020 Sep;15(6):1011-1019. doi: 10.1007/s11739-019-02267-1. Epub 2020 Jan 7.

2020
AO Alessandria

Numico G; Bellini R; Zanelli C; Ippoliti R; Boverio R; Kozel D; Davio P; Aiosa G; Bellora A; Chichino G; Ruiz L; Ladetto M; Polla B; Manganaro M; Pistis G; Gemme C; Stobbione P; Desperati M; Centini G;

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. in The Lancet. Haematology / Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.

2020
AO Alessandria
ASL Biella
AOU Città della Salute di Torino
ASL Torino 5
AOU Novara

Grossi PA; Corradini P; Pagano L; Corrao G; Bertù L; Franchi M; Visco C; Rigacci L; Armiento D; Pane F; Oberti M; Zappasodi P; Galieni P; Fava C; Candoni A; Venditti A; Pinto A; Marchesi F; Musto P; Federici AB; Olivieri A; Gentile M; Bocchia M; Selleri C; Ortu La Barbera E; Ferrandina C; Di Renzo N; Luppi M; Scattolin AM; et alii...

Minimal Residual Disease in Mantle Cell Lymphoma: Methods and Clinical Significance. in Hematology/oncology clinics of North America / Hematol Oncol Clin North Am. 2020 Oct;34(5):887-901. doi: 10.1016/j.hoc.2020.06.006. Epub 2020 Aug 5

2020
AO Alessandria

Ladetto M; Tavarozzi R; Pott C;

Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2020 Jan;31(1):17-29. doi: 10.1016/j.annonc.2019.10.010. Epub 2019 Dec 4.

2020
AO Alessandria

Zucca E; Arcaini L; Buske C; Johnson PW; Ponzoni M; Raderer M; Ricardi U; Salar A; Stamatopoulos K; Thieblemont C; Wotherspoon A; Ladetto M;

Droplet Digital PCR Assay for MYD88 (L265P) : Clinical Applications in Waldenström Macroglobulinemia. in HemaSphere / Hemasphere. 2020 Jan 3;4(1):e324. doi: 10.1097/HS9.0000000000000324. eCollection 2020 Feb.

2020
AOU Città della Salute di Torino
AO Alessandria

Boccadoro M; Drandi D; Ferrero S; Ladetto M; Cavallo F; Omedè P; Benevolo G; Bertuzzo D; Ferrero B; Zamò A; Dogliotti I; Ferrante M; Lo Schirico M;

Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma. in Hematological oncology / Hematol Oncol. 2020 Dec;38(5):698-704. doi: 10.1002/hon.2792. Epub 2020 Aug 28.

2020
AO Alessandria
AOU Città della Salute di Torino

Ladetto M; Foà R; Guarini A; Cortelazzo S; Martelli M; Di Rocco A; Galimberti S; Gattei V; Degan M; Bomben R; Grassi S; Ciabatti E; Barbero D; Monitillo L; Ferrante M; Drandi D; Mantoan B; Genuardi E; Soscia R; Novelli N; Cavalli M; De Novi LA; Della Starza I; Ferrero S; Del Giudice I;

Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network. in HemaSphere / Hemasphere. 2020 Apr 3;4(2):e347. doi: 10.1097/HS9.0000000000000347. eCollection 2020 Apr.

2020
AOU Città della Salute di Torino
AO Alessandria

Macintyre E; Pott C; Ladetto M; Delfau-Larue MH; Hermine O; Dreyling M; Cortelazzo S; Eckert C; Ribrag V; Abdo C; Callanan M; Ciabatti E; Bomben R; Jimenez C; Starza ID; Villarese P; Cheminant M; Genuardi E; Mantoan B; Ferrante M; Lhermitte L; Zaccaria G; Ferrero S; Söhlbrandt A; Benmaad I; Alcantara M; Drandi D;

EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas. in HemaSphere / Hemasphere. 2020 Mar 11;4(2):e351. doi: 10.1097/HS9.0000000000000351. eCollection 2020 Apr.

2020
AO Alessandria

Ladetto M; Dreyling M;

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies. in Frontiers in immunology / Front Immunol. 2021 Feb 2;11:613954. doi: 10.3389/fimmu.2020.613954. eCollection 2020.

2020
AOU Città della Salute di Torino
AO Alessandria

Duarte RF; Basak GW; Greinix H; Penack O; Schoemans H; Koenecke C; Yakoub-Agha I; Kroschinsky F; Scheid C; Sengeloev H; Niederwieser D; Ladetto M; Afanasyev B; Corradini P; Kröger N; Castagna L; Rambaldi A; Socié G; Bruno B; Solano C; Chevallier P; Bourhis JH; Ciceri F; Reményi P; Milpied N; Blaise D; Kanfer E; van der Werf S; Beohou E; et alii...

Minimal Residual Disease-Driven Treatment Intensification By Sequential Addition of Ibrutinib to Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: Results of the Monotherapy and Combination Phases of the Improve Study in Blood

2020
AOU Città della Salute di Torino
AO Alessandria

Scarfo L; Heltai S; Albi E; Scarano E; Schiattone L; Farina L; Gaidano G; Deodato M; Ferrario A; Motta M; Reda G; Sancetta R; Coscia M; Ladetto M; Laurenti L; Varettoni M; Perotta E; Capasso A; Ranghetti P; Colia M; Ghia P;

Daratumumab after Allogeneic Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Safety and Efficacy. a Retrospective Study from the Cmwp EBMT in Blood

2020
AO Alessandria

Vincent L; Gras L; Ceballos P; Finke J; Passweg J; Robin M; Rosinol L; Minnema MC; Teipel R; Van Deosum JA; Haenel M; Lenain P; Forcade E; Koenecke C; Ducastelle S; Sanz J; Schroyens W; Zuckerman T; Ladetto M; Koster L; de Wreede LC; Hayden PJ; Schönland S; Yakoub-Agha I; Beksac M;

A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines. in Haematologica / Haematologica. 2019 Sep;104(9):e410-e414. doi: 10.3324/haematol.2018.212811. Epub 2019 Feb 28.

2019
AOU Città della Salute di Torino
AO Alessandria

Bomben R; Gattei V; Zamò A; Ladetto M; Ferrero S; Bo MD; Bulian P; Zaja F; Degan M; Rossi FM; Bittolo T; Tissino E; D'Agaro T; Zucchetto A; Vit F;

Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes. in JCO clinical cancer informatics / JCO Clin Cancer Inform. 2019 Oct;3:1-15. doi: 10.1200/CCI.19.00049.

2019
AOU Città della Salute di Torino
AO Alessandria

Balestra G; Omedè P; Zamò A; Ferreri A; Ballerini F; Molinari AL; Arcaini L; Lo Schirico M; Castagneri C; Barbero D; Sandrone R; Genuardi E; Evangelista A; Ghislieri M; Rosati S; Ferrero S; Zaccaria GM; Boccadoro M; Cortelazzo S; Ladetto M;

Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network. in Hematological oncology / Hematol Oncol. 2019 Oct;37(4):368-374. doi: 10.1002/hon.2652. Epub 2019 Aug 16.

2019
AO Alessandria

Della Starza I; Cavalli M; De Novi LA; Genuardi E; Mantoan B; Drandi D; Barbero D; Ciabatti E; Grassi S; Gazzola A; Mannu C; Agostinelli C; Piccaluga PP; Bomben R; Degan M; Gattei V; Guarini A; Foà R; Galimberti S; Ladetto M; Ferrero S; Del Giudice I;

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial. in Haematologica / Haematologica. 2019 Nov;104(11):2241-2248. doi: 10.3324/haematol.2018.209932. Epub 2019 Apr 11.

2019
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria

Tarella C; Ladetto M; Corradini P; Passera R; Gianni AM; Rambaldi A; Billio A; Gueli A; Mantoan B; Angrilli F; Perrone T; Semenzato G; Lanza F; Parvis G; Dondi A; Narni F; Zallio F; Zoli V; Devizzi L; Tucci A; Rota-Scalabrini D; Di Raimondo F; Stelitano C; Ciceri F; Rossini F; Castellino C; Gini G; Liberati AM; Musso M; et alii...

Outcomes Following Second Allogenic Haematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of EBMT in Blood

2019
AO Alessandria

Kröger N; Angelucci E; Wang J; Robin M; Nabergoj M; Poire X; Passweg JR; Dreger P; Platzbecker U; Robinson S; Rambaldi A; Sengeloev H; Bornhäuser M; Stelljes M; Ciceri F; Mayer J; Ladetto M; de Wreede LC; Koster L; Hayden PJ; Czerw T; Hernandez Boluda JC; McLornan DP; Chalandon Y; Yakoub-Agha I;

Minimal Residual Disease in Indolent Lymphomas: A Critical Assessment. in Current treatment options in oncology / Curr Treat Options Oncol. 2018 Nov 6;19(12):71. doi: 10.1007/s11864-018-0594-1.

2018
AO Alessandria

Ladetto M; Ferrero S; Ferrante M; Genuardi E; Grimaldi D;

A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial. in Haematologica / Haematologica. 2018 May;103(5):849-856. doi: 10.3324/haematol.2017.184325. Epub 2018 Feb 22.

2018
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Ladetto M; Cortelazzo S; Gaidano G; Wiestner A; Piccin A; Liu D; Luminari S; Arcaini L; Rigacci L; Rusconi C; Vitolo U; Omedè P; Zamò A; Evangelista A; Carella AM; Re A; Dal Bo M; D'Agaro T; Ferrero S; Bomben R; Gattei V;

Highly sensitive MYD88(L265P) mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia. in Haematologica / Haematologica. 2018 Jun;103(6):1029-1037. doi: 10.3324/haematol.2017.186528. Epub 2018 Mar 22.

2018
AOU Città della Salute di Torino
AO Alessandria

Ferrero S; Ladetto M; Boccadoro M; Sanz RG; Galimberti S; Cavallo F; Benevolo G; Orsucci L; Passera R; Omedè P; Zaccaria GM; Drandi D; Genuardi E; Dogliotti I; Ferrante M; Jiménez C; Guerrini F; Schirico ML; Mantoan B; Muccio V; Lia G;

Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up. in British journal of haematology / Br J Haematol. 2018 Jun;181(5):693-695. doi: 10.1111/bjh.14681. Epub 2017 Apr 2.

2018
AO Alessandria

Ghione P; Genuardi E; Rossi D; Drandi D; Mantoan B; Barbero D; Bernocco E; Monitillo L; Cerri M; Ruggeri M; Omede P; Deambrogi C; De Paoli L; Passera R; Coscia M; Cavallo F; Massaia M; Boccadoro M; Gaidano G; Ladetto M; Ferrero S;

STAble: a novel approach to de novo assembly of RNA-seq data and its application in a metabolic model network based metatranscriptomic workflow. in BMC bioinformatics / BMC Bioinformatics. 2018 Jul 9;19(Suppl 7):184. doi: 10.1186/s12859-018-2174-6.

2018
AO Alessandria

Liò P; Ladetto M; Favero F; Conway M; Bona E; Saggese I; Manzini G; Mignone F;

Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi. in Leukemia & lymphoma / Leuk Lymphoma. 2018 Dec;59(12):2904-2910. doi: 10.1080/10428194.2018.1452208. Epub 2018 Apr 4.

2018
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Levis A; Fanin R; Bushell K; Morin R; Alcaide M; Mann KK; Assouline S; Volpetti S; Perali G; Cavallo F; Piccaluga PP; Lenti V; Patti C; Pileri SA; Tucci A; Califano C; Zinzani PL; Chiappella A; Vitolo U; Zanni M; Ladetto M; Gaidano G; Angelucci E; Ciccone G; Evangelista A; Sabattini E; Rossi M; Zaja F; Salvi F; et alii...

Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis. in International journal of laboratory hematology / Int J Lab Hematol. 2018 Apr;40(2):201-208. doi: 10.1111/ijlh.12766. Epub 2017 Dec 4.

2018
AO Alessandria

Genuardi E; Barbero D; Dogliotti I; Mantoan B; Drandi D; Gambella M; Zaccaria GM; Monitillo L; Della Starza I; Cavalli M; De Novi LA; Ciabatti E; Grassi S; Gazzola A; Mannu C; Del Giudice I; Galimberti S; Agostinelli C; Piccaluga PP; Ladetto M; Ferrero S;

The engineered MIPI (E-MIPI), a candidate data-mining based mantle cell lymphoma prognostic index developed from the dataset of the fondazione italiana linfomi (FIL) MCL0208 phase iii trial in Blood

2018
AOU Città della Salute di Torino
AO Alessandria

Zaccaria GM; Ferrero S; Passera R; Evangelista A; Loschirico M; Dogliotti I; Ghislieri M; Genuardi E; Bomben R; Gattei V; Ciccone G; Tani M; Gaidano G; Volpetti S; Cabras MG; Di Renzo N; Merli F; Vallisa D; Spina M; Pascarella A; Latte G; Patti C; Pozzato G; Fabbri A; Cortelazzo S; Ladetto M;

Droplet Digital PCR for Minimal Residual Disease Detection in Mature Lymphoproliferative Disorders. in Methods in molecular biology (Clifton, N.J.) / Methods Mol Biol. 2018;1768:229-256. doi: 10.1007/978-1-4939-7778-9_14.

2018
AO Alessandria

Drandi D; Ferrero S; Ladetto M;

Immunoglobulin kappa deleting element (IGK-KDE) rearrangements as possible target for minimal residual disease (MRD) evaluation in mantle cell lymphoma (MCL) in Haematologica

2018
AO Alessandria

Della Starza I; De Novi LA; Cavalli M; Novelli N; Genuardi E; Mantoan B; Drandi D; Ferrante M; Monitillo L; Barbero D; Ciabatti E; Grassi S; Bomben R; Degan M; Gattei V; Galimberti S; Di Rocco A; Martelli M; Cortelazzo S; Guarini A; Foa R; Ladetto M; Ferrero S; Del Giudice I;

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi. in Haematologica / Haematologica. 2017 May;102(5):e203-e206. doi: 10.3324/haematol.2016.154211. Epub 2017 Jan 12.

2017
AOU Città della Salute di Torino
AO Alessandria

Ladetto M; Montechiarello E; Drandi D; Ferranti A; Volpetti S; Ceccarelli M; Pileri SA; Minotto C; Liberati AM; Patti C; Cellini C; Spina M; Botto B; Musuraca G; Arcari A; Salvi F; Ferrari A; Carmichael J; Fanin R; Stelitano C; Zaja F; Ferrero S;

Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Feb 10;35(5):552-560. doi: 10.1200/JCO.2016.70.8651. Epub 2016 Dec 28.

2017
AOU Città della Salute di Torino
AO Alessandria

Sargent DJ; Salles G; Zucca E; Morschhauser F; Ladetto M; Hoster E; Fowler NH; Valente N; Fu T; De Bedout S; Nielsen T; Ghielmini M; Gyan E; Peterson BA; Vitolo U; Hochster H; Kimby E; Hagenbeek A; Herold M; Marcus R; Hiddemann W; Flowers CR; Shi Q;

Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas. A pooled-data analysis of 12 clinical trials of Fondazione Italiana Linfomi (FIL). in Thrombosis and haemostasis / Thromb Haemost. 2017 Apr 27. doi: 10.1160/TH16-11-0895.

2017
AOU Città della Salute di Torino
AO Alessandria

Ceccarelli M; Bernocco E; Monagheddu C; Evangelista A; Valeri F; Monaco F; Vitolo U; Cortelazzo S; Cabras MG; Spina M; Baldini L; Boccomini C; Chiappella A; Bari A; Luminari S; Visco C; Calabrese M; Limberti G; Levis A; Contino L; Ciccone G; Ladetto M; Santi RM;

DELPHI, a data warehouse to discover associations between variables in clinical trials: Application to the fondazione italiana linfomi (FIL) mcl0208 phase iii trial in Blood

2017
AO Alessandria

Zaccaria GM; Ferrero S; Evangelista A; Rosati S; Castagneri C; Ghislieri M; Daniela B; Genuardi E; Schirico ML; Zamò A; Vitolo U; Bomben R; Gattei V; Galimberti S; Di Paolo A; Rossi D; Gaidano G; Di Rocco A; Cortelazzo S; Boccadoro M; Balestra G; Ladetto M;

Standardized IGH-based next-generation sequencing for MRD detection in follicular lymphoma in Blood

2017
AO Alessandria

Pott C; Knecht H; Herzog A; Genuardi E; Unterhalt M; Mantoan B; Dogliotti I; Hiddemann W; Boccadoro M; Herrmann D; Kneba M; Langerak AW; Darzentas N; Groenen P; Brüggemann M; Hoster E; Ladetto M; Ferrero S;

Targeted locus amplification (TLA): A novel next generation sequencing (NGS) technology to detect new molecular markers and monitoring minimal residual disease (MRD) in mantle cell and follicular lymphoma in Blood

2017
AO Alessandria

Genuardi E; Klous P; Drandi D; Mantoan B; Monitillo L; Daniela B; Yilmaz M; Cattellino F; Vasta M; Furia F; Zaccaria GM; Cavallo F; Cortelazzo S; Vitolo U; Luminari S; Federico M; Boccadoro M; Splinter E; Ladetto M; Ferrero S;

ABC subtype, TP53 mutation and BCL2 overexpression are associated with a worse outcome in untreated poor-risk young diffuse large B-cell lymphoma: Results from the frontline phase iii bio-DLBCL04 study of the fondazione italiana linfomi in Blood

2017
AO Alessandria

Chiappella A; Agostinelli C; Ladetto M; Evangelista A; Martelli M; Angelucci E; Balzarotti M; Bomben R; Cabras MG; Diop F; Fabbri M; Gotti M; Melle F; Merli F; Motta G; Nassi L; Novero D; Righi S; Rossi D; Rossi G; Stelitano C; Gattei V; Gaidano G; Pileri SA; Vitolo U;

Targeted locus amplification (TLA) to identify novel, translocation-based, molecular markers for minimal residual disease (MRD) monitoring in mantle cell and follicular lymphoma in Haematologica

2017
AO Alessandria

Genuardi E; Ferrero S; Klous P; Drandi D; Mantoan B; Monitillo L; Barbero D; Yilmaz M; Cattellino F; Vasta M; Cavallo F; Cortelazzo S; Vitolo U; Luminari S; Federico M; Boccadoro M; Splinter E; Ladetto M;

Hashclone: A new bioinformatics suite to quantify minimal residual disease by next-generation sequencing in B-cell lymphoma in Haematologica

2017
AO Alessandria

Genuardi E; Beccuti M; Romano G; Monitillo L; Barbero D; Furia F; Calogero R; Boccadoro M; Ladetto M; Cordero F; Ferrero S;

Minimal residual disease (MRD) evaluation in lymphomas within the FIL (Fondazione Italiana linfomi) MRD network: Inter-laboratory reproducibility on borderline samples in Haematologica

2017
AO Alessandria

Della Starza I; Cavalli M; De Novi LA; Genuardi E; Mantoan B; Drandi D; Monitillo L; Ciabatti E; Grassi S; Gazzola A; Mannu C; Agostinelli C; Piccaluga PP; Galimberti S; Guarini A; Foà R; Ladetto M; Ferrero S; Del Giudice I;

Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma. in Leukemia / Leukemia. 2016 May;30(5):1211-4. doi: 10.1038/leu.2015.269. Epub 2015 Oct 6.

2016
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria

Bruno B; Passera R; Boccadoro M; Palumbo A; Giaccone L; Omedè P; Fanin R; Ghione P; Boccasavia V; Brunello L; Ferrando F; Cena S; Guarona G; Benedetto R; Mordini N; Patriarca F; Festuccia M; Ladetto M; Drandi D; Ferrero S;

Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures. in Dentistry journal / Dent J (Basel). 2016 Dec 1;4(4):45. doi: 10.3390/dj4040045.

2016
AO Alessandria

Catania G; Monaco F; Limberti G; Alessio M; De Martino I; Barile C; Fasciolo A; Baraldi A; Ladetto M; Fusco V;

Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting). in Leukemia & lymphoma / Leuk Lymphoma. 2016;57(6):1256-68. doi: 10.3109/10428194.2015.1131278. Epub 2016 Jan 6.

2016
AO Alessandria
AO Ordine Mauriziano

Schönland S; Palumbo A; Morris C; Massaia M; Lemoli RM; Ladetto M; Festuccia M; Garderet L; Gahrton G; Auner HW; Bruno B; Boccadoro M; Kröger N;

TP53 and KMT2D mutations predict pfs in mcl patients treated with high-dose therapy and autologous transplantation: Results from the MCL0208 phase iii trial from fondazione italiana linfomi (FIL) in Haematologica

2016
AOU Città della Salute di Torino
AO Alessandria

Ferrero S; Rossi D; Bruscaggin A; Ghione P; Di Rocco A; Spina V; Stefoni V; Ciccone G; Barbero D; Monitillo L; Gomes Da Silva M; Santoro A; Molinari A; Ferreri A; Piccin A; Cortelazzo S; Ladetto M; Gaidano G;

A pooled data analysis of twelve clinical trials of fondazione italiana linfomi (FIL): Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in non hodgkin lymphoma in Haematologica

2016
AO Alessandria

Santi RM; Ceccarelli M; Catania G; Monagheddu C; Evangelista A; Bernocco E; Monaco F; Federico M; Vitolo U; Cortellazzo S; Cabras MG; Spina M; Baldini L; Boccomini C; Chiappella A; Bari A; Luminari S; Visco C; Calabrese M; Contino L; Ciccone G; Ladetto M;

Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Sep;26 Suppl 5:v116-25. doi: 10.1093/annonc/mdv304.

2015
AOU Città della Salute di Torino
AO Alessandria

Tilly H; Gomes da Silva M; Vitolo U; Jack A; Meignan M; Lopez-Guillermo A; Walewski J; André M; Johnson PW; Pfreundschuh M; Ladetto M;

Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR. in The Journal of molecular diagnostics : JMD / J Mol Diagn. 2015 Nov;17(6):652-60. doi: 10.1016/j.jmoldx.2015.05.007. Epub 2015 Aug 28.

2015
AOU Città della Salute di Torino
AO Alessandria

Boccadoro M; Cortelazzo S; Palumbo A; Vitolo U; Hajek R; Barberio D; Omedè P; Barbero D; Genuardi E; Ghione P; Saraci E; Monitillo L; Gambella M; Mantoan B; Dani N; Passera R; Ladetto M; Inghirami G; Kubiczkova-Besse L; Ferrero S; Drandi D;

Khorana score and histotype predict the incidence of Early Venous Thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL) in Blood

2015
AO Alessandria

Santi RM; Ceccarelli M; Catania G; Monagheddu C; Evangelista A; Bernocco E; Monaco F; Federico M; Vitolo U; Cortelazzo S; Cabras MG; Spina M; Baldini L; Boccomini C; Chiappella A; Bari A; Luminari S; Calabrese M; Levis A; Contino L; Ciccone G; Ladetto M;

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2014 Jul;25(7):1404-1410. doi: 10.1093/annonc/mdu166. Epub 2014 May 5.

2014
AO Alessandria
AOU Novara

Pulsoni A; Baldini L; Mancuso S; Marino D; Bruno R; Rossi D; Spedini P; Rigacci L; Levis A; Musto P; Ladetto M; Merli F; d'Arco A; Stelitano C; Tucci M; Luminari S; Visco C; Cabras G; Spina M; Tucci A; Rusconi C; Varettoni M; Ambrosetti A; Chiappella A; Merli M; Bernuzzi P; Ferreri AJM; Ferretti VV; Rattotti S; et alii...

An anti-factor Xa chromogenic assay for the measurement of apixaban plasma concentrations in Thrombosis Research

2014
AO Alessandria

Santi R; Contino L; Ciriello MM; Ladetto M;